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ABSTRACT
Systemic Leptin Modulates the Expression of E-cadherin, β– catenin in the Ovary of DietaryInduced Obese Infertile Rats
by
Olufunke Abosede Sokan
One of the numerous complications of obesity is infertility. Leptin has been shown to reverse
infertility; however, exact mechanism is poorly understood. Recent evidence indicates Ecadherin/β-catenin complex, which is a structural constituent of adherens junction, is expressed
in the rat ovary during folliculogenesis. We hypothesized that systemic leptin modulates the
expression of E-cadherin and β catenin in dietary- induced obese infertile rats to reverse
infertility. Female Sprague-Dawley rats were fed either regular chow diet (RCD) (n=6) or high
fat diet (HFD) (n=14). Oestrus cycles were monitored daily until their cycles became irregular.
100 ug/ml of leptin was given intraperitoneally to HFD-fed rats (n=5) with irregular cycles. The
control rats HFD (n=9) and RCD received saline. Leptin treatment restored regular estrous
cycle and increased the expression of E-cadherin and β-catenin in all the 5 rats (HFD+Leptin).
This could represent the mechanism by which leptin reverses infertility in obese infertile rats.
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CHAPTER 1
INTRODUCTION
Leptin
Leptin was discovered in 1994 by Zhang and colleagues while they were studying obesity
among mice (1). Leptin is a 16kDa protein hormone. It plays a role in regulating energy intake
and expenditure which includes appetite, hunger, and metabolism (1). The major source of
leptin is from white adipose tissue (2, 3). It is also secreted from the hypothalamus (4) and
other peripheral tissues, such as brain (4), stomach (5), skeletal muscle (6), placenta (7), and
mammary glands (8, 9).
Function of Leptin in Energy Intake and Expenditure
The level of circulating leptin is proportional to the total amount of fat in the body (10).
Fasting or very low calorie diet has been shown to reduce the level of leptin (3). Reduced level
of leptin promotes food intake in excess of energy expenditure in order to restore body fat mass
(3). In the absence of functional leptin, animals fail to restrain their food intake, which leads to
obesity (1). Leptin usually acts as an afferent hormone regulating appetite, weight gain, and fat
deposition via a negative feedback loop involving the hypothalamus (1). Leptin provides the
body with nutritional index (11). Leptin enters the hypothalamus in proportion to its plasma level
and acts on its receptors. Leptin receptors have been found in the mediobasal part of the
hypothalamus, which include the arcuate (ARC), dorsomedial hypothalamic, and ventromedial
hypothalamic nuclei. These receptors are involved in regulation of energy intake, energy
expenditure, thermogenesis, and pituitary hormone levels (12).
There are 2 populations of neurons found in the ARC that are sensitive to leptin. Leptin is
activated when bound to the first population of neurons, the orexigenic peptides, Neuropeptide
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Y (NPY), and Agouti-Related Protein (AgRP) (13). This activation leads to increase food intake
and reduction in energy expenditure. However, the second population of neurons,
proopiomelanocortin (POMC) and cocaine-and amphetamine-regulated transcript (CART), give
the opposite effect when bound by leptin (10). In the peripheral tissues, leptin modulates
adenosine monophosphate-activated protein kinase (AMPK) (14). Leptin uses the ATPgenerating pathways (fatty acid oxidation) and avoids ATP-consuming pathways, like fatty acid
synthesis, in order to restore energy homeostasis of the cell (14).
Leptin acts as an anorectic hormone to decrease appetite, food intake, and expenditure via
various pathways. This is done in both peripheral and central modes of action in order to
maintain energy balance (7). It is worthy of note that leptin has also been found to be a crucial
hormone for diverse physiological processes such as inflammation, angiogenesis,
hematopoiesis, immune function, and most importantly in reproduction (15).

Leptin and Reproduction
The success of reproduction is much dependent on availability of food and body energy
stores, with adequate distribution of adipose tissue (16). Because leptin level is related to
amount of body fat storage (17), leptin could influence reproductive cycles directly or indirectly.
Likewise, lack of biologically active leptin is associated with infertility (18). Leptin is involved in
centrally regulated maturation of the reproductive structures (19). This was found in obese
female ob/ob mice that were infertile (19). Reversal of their infertility was noted after
exogenous leptin treatment (19). Elevation of serum luteinizing hormone, increase in ovarian
and uterine weights, and stimulation of ovarian and uterine histology were also documented
(20). Some studies have also supported the concept that leptin coordinates the behavioral and
endocrine components of reproductive function with adequate amount of energy stores (21).
10

Leptin and HPG Axis
Leptin accelerates gonadotropin releasing hormone (GnRH) pulsatility (Figure 1), which
plays a major role in fertility (22). However, leptin is not the sole regulator of GnRH secretion
but works in supporting other molecules through distinct signaling mechanisms and pathways
(23). As much as 20% to 25% of the anterior pituitary cells (predominantly folliculostellate and
corticotropes cells) have been found to produce leptin. This may act to regulate pituitary
differentiation and cell growth in addition to its effect on luteinizing hormone and follicular
stimulating hormone secretion (24). Previous work demonstrated that low levels of leptin have
been associated with low levels of luteinizing hormone (LH). This was reversed when leptin
was administered (25).
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LEPTIN
HYPOTHALAMUS

Pre-optic

GnRH
Ant. Pituitary
Increase
FSH

Increase
LH

Folliculization

Ovulation
Figure 1: Mechanisms of action of leptin in reproductive system. Leptin acts on the preoptic
area of the hypothalamus, increasing GnRH secretion. GnRH stimulates anterior pituitary to
release FSH. This causes folliculization in preparedness for ovulation. LH surge initiates
ovulation.
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E-cadherin and Beta-catenin

E-Cadherin

E-cadherins, also known as CAM 120/80, uvomorulin, or epithelial cadherin, are a subtype in
the cadherins family (26). Cadherin family consist of type-1 transmembrane proteins (27). In
this family, there are different subtypes. Each of the subtypes is designated with a prefix
depending on the tissue type. For example, N-cadherin is found in the neurons; K-cadherin in
the kidney; VE-cadherin in the Vascular endothelium; E-cadherin in the epithelia tissues, etc
(28). E-cadherin is the most studied member of the cadherin family (27).

E-cadherin is encoded by CH1 gene (26). It was identified in chicken and was originally
called L-CAM (29). The mouse counterpart of this protein uvomorulin has about 80% identity in
both amino acid nucleotide and sequences to the human counterpart (30). During mammalian
development, e-cadherin is first expressed at the 2-cell stage of mammalian development. It
then becomes phosphorylated by the 8-cell stage where it causes compaction. E-cadherin’s
half-life on the cell surface is 5 hours (29). It is found extracellularly at adherens junctions.
Adherens junctions are cellular structures near the apical surface of polarized epithelial cells.

For E-cadherin to function, it is dependent on calcium (Ca2+) ions (31). It is composed of 5
extracellular cadherin repeats, (E1–E5) in the extracellular domain, a transmembrane domain,
an intracellular domain that binds p120-catenin and beta-catenin, and a highly conserved
cytoplasmic tail (32). The intracellular domain of E-cadherin has a highly phosphorylated region
vital to β-catenin binding. It is known as a tumor suppressor (33) and plays an important role in
cell adhesion (31). E-cadherin ensures that the cells within the tissue are well bound together,
hence playing a vital role in normal tissue development (27). The binding of p120 to intracellular
domain of E-cadherin regulates cadherin adhesive activity and trafficking. Meanwhile the
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binding of β-catenin and γ-catenin play a structural role in junctional complex. E-cadherincontaining cell-to-cell junctions are often adjacent to actin-containing filaments of the
cytoskeleton in epithelial cells (31). In addition to the E-cadherin role in normal cells, it can play
a major role in malignant cell transformation, tumor development, and progression (31).

β-Catenin
β-catenin is a human protein that was found initially to be a member of Armadillo family of
proteins (Homologous protein in drosophila) (34). It is encoded by CTNNB1 gene (34), and the
structure has been determined (35). β-catenin family proteins have been found to contain
several ARM repeats, sequences of approximately 50 amino acids that are involved in proteinprotein interactions. Each of these repeat consists of 3 helices with helix 1 and 3 parallel to
each other and helix 3 perpendicular to helix 1 and 3 (7).
β-catenin can be found inside the cell forming complexes with cadherins, axin (a component
of the Wnt signaling pathway), galectin-3,transcription factors, and beta-galactoside-binding
protein (36). It also associates with α-catenin, ICAT (β-catenin interactive protein 1), and APC
(Adenomatous polyposis coli) (37). The ability for β-catenin to bind to other proteins is
regulated by tyrosine kinase and serine kinases like GSK-3 (38, 39). It serves as an anchor to
the actin cytoskeleton (38). This may be responsible for transmitting contact inhibiting signal
that makes cells stop dividing once the epithelial sheet is complete.
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Canonical Wnt /β-catenin Signaling Pathway
Wnt signaling pathway is a network of several proteins that passes signals from receptors on
the cell surface through the cytoplasm to the cell’s nucleus (40-42). Compositions of the
network are secreted glycoprotein, Wnt family ligand, frizzled and low-density lipoprotein (LDL)
receptor-related protein (LRP) families of receptors (40-42). These signals further initiate
signaling cascade that lead to expression of target genes (41). Wnt signaling pathway controls
cell-cell communication during embryo development, adult cell proliferation, and differentiation
during development and healing (43, 44). During development, the Wnt signaling pathway
regulates diverse processes, such as cell fate determination, cell polarity, and morphology,
structural remodeling and most importantly cell adhesion and growth (40-45). The frizzled
receptor component of Wnt signaling pathway is involved in 2 distinct pathways known as
canonical or non-canonical pathways (45). The presence or absence of β-catenin is the
difference between these two categories of pathways (45).
The canonical Wnt pathway (Wnt/β-catenin signaling pathway) regulates β-catenin
stabilization and gene expression, thereby causing its accumulation in the cytoplasm (46). βcatenin acts as an intracellular signal transducer in the canonical Wnt signaling pathway (47).
The non-canonical pathway is the signaling pathway that regulates cell polarization (PCP) (48).
This is a process that establishes the uniform alignment of structures in the epithelium (48).
Normal levels of β-catenin are needed to associate with cadherins to promote cell adhesion
and also control cell shape with the microfilament cytoskeletal network (49). Without a normal
level, β-catenin will not be able to carry out its numerous functions (49). Normal levels of
cytoplasmic β-catenin are maintained by a regulated process that directs degradation of excess
β-catenin (49). In the cytoplasm, β- catenin degradation as shown in figure 2a involves
phosphorylation by GSK3beta (37, 49, 50). Cyclin-CDK2 primes β-catenin for phosphorylation
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by GSK3beta (49, 50). This phosphorylation occurs within the so-called “destruction-complex”
scaffold by the tumor suppressors AXINS (49, 50). Tumor suppressor APC (Adenomatous
polyposis coli) is also required within this destruction complex for an efficient degradation of βcatenin (37). Phosphorylated beta-catenin is then bound by the beta-TrCP component of
ubiquitin ligase complex and β-catenin is degraded. GSK3beta, which is constitutively active,
must be inhibited to prevent the degradation of β-catenin in order for β-catenin to carry out its
functions (50). This is where canonical Wnt signaling pathway is involved (51).

Canonical Wnt signaling pathway, (figure 2b), through frizzled and LRP receptor (LRP5/6)
pair, activates dishevelled (Dvl) and inhibits GSK3beta. This allows accumulation of β-catenin in
the cytoplasm, hence its ability to migrate to the nucleus. β-catenin enters the nucleus and
interacts with transcription factors and gene regulators, such as T-cell factor (TCF)/lymphoid
enhancer factor (LEF) to mediate gene expression (28, 29). Already bound β-catenins (e.g. Ecadherin/β-catenin complex) as shown in figure 2c, are not affected by this degradation.
However, the degradation affects the availability of β-catenin to bind to E-cadherin and other
proteins (52).
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Canonical Wnt/β-catenin Signaling Pathway and E-cadherin/β-catenin complex

Figure 2: A. The degradation of beta-catenin by GSK3beta complex. B. Wnt/β catenin signaling
pathway enhances accumulation of beta-catenin in the cytoplasm. C. E-cadherin/β-catenin
complex.

E-cadherin/β- catenin Complex
β-catenin is part of a complex that constitutes adherens junctions (27, 31). These adherens
junctions are needed for the creation and maintenance of epithelial cell layers, through
regulation cell growth and adhesion between cells (27).
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E-cadherin and β-catenin complex play a crucial role in maintaining epithelial integrity (27,
31). Cell-cell junctions in tissues help to maintain cell and tissue integrity and polarity. In
vertebrate animals, there are intercellular junctions systems, namely: Gap junctions (that act as
intercellular channels and allow direct cell-cell transfer of small molecules and ions); Tight
junctions (the major cellular determinant of epithelial barrier function); Anchoring junctions
(these are desmosomes and adheren junctions that interact with the cortical cytoskeleton to
mediate cell and tissue behavior) (53). Among the structural molecule constituents that
assemble to form the adheren junctions is the E-cadherin/β-catenin complex (53). The
extracellular region of E-cadherin spans from the cell surface of a particular cell to other
subtypes of cadherins present on adjacent cells. The intracellular region contains binding sites
to interact with β-catenins and other regulatory proteins (54). β-catenin binds to the carboxylterminal 100 amino acids of the cadherin cytoplasmic region. Actin cytoskeleton, which has the
ability to promote adherens junction protein clustering and stabilization of cell adhesion, is
bound to beta-catenin by alpha-catenin (55, 56).

Presence of E-cadherin and β-catenin in Ovary and It’s Relation to Ovulation
Folliculogenesis
In mammals there are different dynamic changes that occur during reproduction cycle. The
different ovarian compartments are subjected to both differentiation and proliferation events that
are regulated by paracrine and endocrine factors (57). Human ovaries normally produce a
single dominant follicle that results in a single ovulation during each menstrual cycle (57). The
development and maturation of this dominant ovarian follicle involves structural changes that
require altered expression and function of the component involved in cell-cell contacts (58).
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Intercellular communication through the cell-cell adhesion is crucial in the maintenance of tissue
integrity and function (59).

Folliculogenesis is the process of attaining successively higher levels of cell organization by
means of cytodifferentiation and cell proliferation of the ovarian follicle (60). This process
occurs within the cortex of the ovary (56). The recruitment of a primordial follicle into the pool of
growing follicles is the beginning of folliculogenesis (57). This ends with either ovulation or
death by atresia. Folliculogenesis includes 4 major developmental events as shown in figure 3
below: 1) primordial follicle recruitment; 2) pre-antral follicle development; 3) selection and
growth of antral follicle; and 4) follicle atresia (60-62). The pre-antral phase (gonadotropinindependent phase) is characterized by growth and differentiation of the oocyte and controlled
by locally produced growth factors through paracrine/autocrine mechanisms (56-58). A
primordial follicle consists of a single layer of flattened or squamous granulosa cells. These
granulosa cells are closely juxtaposed to the oocyte and a basal lamina (56). Primordial follicles
are formed in the human fetus from the sixth to ninth month of gestation and are arrested in the
dictyate stage of meiosis (58). Some of these primordial follicles are recruited to grow soon
after their formation in the fetus. This is termed recruitment or primordial follicle activation (56).
As the female develops and grows into puberty, the primordial follicle becomes primary follicle.
The primary follicle is characterized by a single layer of one or more cuboidal cells arranged
around the oocyte (56-58). It is during the conversion of primordial follicles to primary follicles
that the importance of cell-cell contacts arises (29). There is a development of intimate
intercellular connections between the oocyte and granulosa cells (63). It is believed that the
effectiveness of adherens junctions and gap junctions in these regions is important in primary
follicle development (59). The importance of oocyte-granulosa intercellular connections makes
the E-cadherin/β-catenin complex a potential candidate for a crucial role in folliculogenesis. E-

19

cadherin/β-catenin is a structural constituent in formation of adherens junction. This support the
recent finding of expression of E-cadherin and β-catenin in normal rat ovaries (64, 65).

As the pre-antral folliculogenesis continues, the primary follicle develops into secondary
follicle. Secondary follicle development includes the accumulation of multiple layers of granulosa
cells around the oocyte and the acquisition of theca cells (theca interna and theca externa) (66).
This process is regulated by autocrine/paracrine mechanisms that involve growth factors
produced by the oocyte (56-58). Primary-to-secondary transition involves the ability to stimulate
granulosa cell proliferation and continual development of inter-cellular junction system between
the granulosa cells and oocyte-granulosa intercellular connections (59).

The antral phase (gonadotropin-dependent phase) is associated with tremendous size
increase of the follicle (25-30mm) and regulated by follicular stimulating hormone (FSH),
luteinizing hormone (LH), and growth factors (57). Determination of how these growth factor
pathways negatively or positively regulate folliculogenesis, ovulation, and luteogenesis is not
completely understood. The hallmark of the antral phase is the appearance of epitheloid cells in
the theca interna and development of a fluid filled antrum (61). The overall size of the antral
follicle is determined by the size of the antrum (follicular fluid) and proliferation of the follicle
cells (granulosa and theca cells) (57). Cessation of increase in follicular fluid and mitosis under
hormonal influence leads to follicular atresia. All the granulosa cells express FSH receptors
during antral follicle development. This enables them to respond to FSH in many ways,
including induction of luteinizing hormone (LH) receptors (57). The stimulation by
gonodotrophins and growth factors causes the growth of the follicle and granulosa cell
differentiation, leading to pre-ovulatory follicle. An LH surge causes follicular rupture (ovulation)
and formation of corpus luteum (57, 62, 67). Constant communication between the oocyte and
its surrounding granulosa cells results in maturation of a fertilizable oocyte (59, 63).
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Figure 3: Folliculogenesis. The pre-antral and antral follicular growth phase of folliculogenesis.
(adapted from (69) )
Expression of E-cadherin/β-catenin in Rats Ovaries

E-cadherin/β-catenin complex plays an important role during tissue development and
differentiation of many organs (68). The modulation of E-cadherin-β-catenin expression is an
integral component of remodeling processes including corpus luteum formation in the ovary
(64). Recent studies have suggested the presence of this complex in the theca-interstitial cells
surrounding pre-ovulatory follicles and pre-antral follicles located in the inner region of the ovary
(58, 64, 65). E-cadherin/β-catenin complex has been expressed in the rat ovary during
folliculogenesis and luteal formation (65). Expressions of E-cadherin and β-catenin were found
to be increased in the theca and interstitial cells of the rat ovaries during follicular development.
However, granulosa cells had more expression of β-catenin (65).
The concentration of E-cadherin and β-catenin were found to be constant during the follicular
phase and present in most ovarian cells at all stages of folliculogenesis (58, 64, 65). This
makes them have the potential to participate in the regulation of cytoskeletal structures and
intracellular signaling. Studies have shown that modulation of E-cadherin/β-catenin complex
expression is an integral component of remodeling processes that includes corpus luteum
formation in the ovary and folliculogenesis (61). The complex is under hormonal control during
these processes (20, 34). The possibility of E-cadherin having a ‘barrier-function’ role in limiting
21

the accessibility of immune system to the follicular compartment during folliculogenesis has also
been postulated (42).

These evidences suggest the involvement of these proteins in reproductive processes.
However, the molecule modulating the expression of these proteins (E-cadherin and β-catenin)
in these ovarian cells is unknown at the moment. Because leptin is a ploteotropic hormone
involved in many physiological processes including reproduction (15), the fundamental
questions to be answered are: 1. Is it possible that the direct involvement in modulation of
expression of these proteins could be one of leptin actions that has not yet been identified?; and
2. Does leptin work to reverse dietary-induced infertility in an obese rat by modulating Ecadherin and β-catenin expression in ovarian cells? This study was designed to answer these
questions.
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CHAPTER 2
MATERIALS AND METHODS

Animals Model
Twenty female Sprague-Dawley rats of the same age with the weight range of 220-260g
were acquired from Harland and used in this study (Protocol #100501). The animal use
protocol was approved by the University committee on animal care (UCAC) of East Tennessee
State University. The animals were housed individually and kept in a well-controlled, specific
pathogen-free room, located in Brown Hall DLAR facility at ETSU. Food and water were made
available ad libitum. Six of the rats were given regular chow diet (RCD), and the remaining 14
were fed with high Fat diet (HFD).
Determination of Oestrous Cycle and Vaginal Cytology
The oestrus cycles were checked daily for each of the rats. A regular 4-day cycle as shown
in figure 4, consists of proestrus, estrus, metestrus, and diestrus.
Vaginal Cytology
In determining the different stages of the estrous cycle, a wet mount process was conducted
to visualize the vaginal cytology. A small amount (10µl) of saline solution was introduced into
the vaginal orifice of each female rat and then aspirated and placed on a clean dry slide. The
cells were then examined under a compound microscope at 10X and 40X for analysis. Using a
digital camera microscope (manufactured by Nikonci, Japan (Figure 6), pictures were taken.
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Oestrus Cycle

Figure 4: Vaginal smears pictures that were taken at 10X using digital camera microscope.
Each of the pictures represents 1 of the 4 cycles of oestrus. (A) Proestrus: predominance of
nucleated epithelial cells. (B) Estrus: predominance of anucleated cornified cells. (C) Metestrus:
includes nucleated epithelial cells, anucleated cornified cells, and leukocytes. (D) Diestrus:
predominance of leukocytes.
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Irregular Oestrus Cycle
The irregularity of the oestrus cycle as shown in figure 5, of those rats given HFD was
noticed towards the end of the 12th week of the study, which signified the occurrence of
infertility. The regularity of oestrus cycle is determined by a 4-day cycle that consists of:
proestrus, estrus, metestrus, and diestrus. Ability of each rat to go through this cycle day by
day without skipping any stage signifies a regular oestrus cycle.

Figure 5: Representation of an irregular oestrus cycle. The cycle moved from (A) Proestrus:
predominance of nucleated epithelial cells, to (B) Metestrus: includes nucleated epithelial cells,
anucleatedcornified cells, and leukocytes, skipping Estrus and being detained in (C) Diestrus:
predominance of leukocytes.
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Figure 6: Using a digital camera microscope (manufactured by Nikonci, Japan), pictures were
taken at 10X and 40X magnification for analysis.

Overview
Diet-induced obesity in rats has been found to lead to infertility in both female and male rats
(15). Leptin is involved in centrally regulated maturation of the reproductive system. The
infertility of obese female ob/ob mice can be reversed by leptin treatment (15). In order to study
leptin modulation of expression on E-cadherin, β-catenin in dietary- induced obese infertile rats,
some of these female rats were given HFD daily. Their weight, food intake, and oestrus cycle
were checked daily until the oestrus cycle became irregular.
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Six were given RCD and 14 HFD. By the 13th week, 5 out of the 14 female rats that were fed
HFD had irregular oestrus cycle earlier than the remaining 9. These were the rats that were
treated with leptin. 100ug/ml of leptin was injected to each of the 5 female rats intra-peritoneally
(morning and evening) for 2 days. The remaining 9 given HFD and the 6 with RCD were
injected with saline. Their body weight and food intake were measured twice weekly and the
estrus cycle checked daily.
Statistical Analysis
t-test, one-way ANOVA, two-way ANOVA were used to calculate the significant difference of
the average weight change and food intake amongst the rats. The level of significance was set
at (p < 0.05).

Tissue Harvesting
At the end of the 14th day when the oestrus cycle of those treated with Leptin became
regular, the 20 female rats were sacrificed by decapitation. Ovariectomy was done in each rat,
and the ovaries were frozen on dry ice and stored at -80 degree until processed for
homogenization and Western Blotting.
E-cadherin and β- catenin Identification and Quantification
E-cadherin and β-catenin protein expression was examined using Western Blots. Each
sample was homogenized using RIPA lysis buffer (Triton X-100 10%, Sodium Deoxycholate
1%, SDS 0.10%, NaCl 0.15M, NaH2P04 0.01M, NaF 50mM,EDTA 2mM) containing Protease
Inhibitor Cocktail (Thermo scientific, #78442) and the cell lysates extracted upon refrigerator
centrifugation. The protein concentration of the cell lysates were determined by Bicinchoninic
acid Assay (BCA) protein (Pierce Biotechnology, Rockford, IL, USA). Proteins were separated
27

by electrophoresis on 10% SDS-polyacrylamide gel and electro-transferred onto Hybond-ECL
nitrocellulose membranes. Blotted membranes were blocked overnight with 5% skimmed milk
and incubated with primary antibodies diluted 1 to 200 in 5% BSA. Antibodies from Santa Cruz
Biotechnology (Santa Cruz,CA,USA ) included E-cadherin (sc #3195) Beta-catenin (sc #2698).
Beta actin was obtained from sigma (F3022). After primary antibody incubation the blots were
probed with appropriate secondary antibody conjugated with horseradish peroxidase. The
signal was visualized using Super Signal West Dura chemiluminescence substrate (Pierce
Biotechnology). Blot images were obtained using the G-box i-chemi XR CCD (Syngene
Corporation).
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CHAPTER 3
RESULTS
Leptin Effect on Body Weight
The body weight of RCD+ Saline (S), control, and HFD+ Saline (S) were monitored daily
throughout the study with a use of digital scale (Mettler Toledo,OH). The average data (table 1)
and figure (figure 7) are showed below. This parameter was measured in order to see the
difference in body weight change as a result of the type of diet. There was a significant
difference between the weight gain of RCD+S and HFD+S. The HFD+S had more weight gain
than RCD+S.
Table 1: This data shows the difference in the total weight gain at the end of the study between
RCD+S (n=6) vs HFD+S (n=9) rats.
Average Weight Gain of RCD+S and HFD+S At The End Of the Study(g)
RCD+S

HFD+S

24.5

43.1

28.8

35.5

18.6

42.1

8.3

25.1

17

33.1

30

33.4
44.6
28.5
30.3

Mean

Mean

21.2

35.08

SEM

SEM

3.35

2.29
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Average Weight Gain of RCD+S and HFD+S at the End of the Study (g)

Figure 7: Comparison of average body weight gain of RCD+S and HFD+S at the end of the
study. The body weight gain of HFD+S was significantly (p<0.05) higher than RCD+S using a
Two-sample t-test analysis. (

* significant difference)

Leptin Induces Weight Loss
By the 7th day, the oestrus cycle of those treated with leptin (n=5) started showing signs of
regularity. By the 13th day, the oestrus cycle of the 5 female rats (HFD+Leptin) became regular,
and that of the remaining 9 HFD fed female rats were fully irregular. A significant weight loss
occurred in the HFD+Leptin (n=5) rats. The table (table 2) and figure (figure 8) below represent
these changes.
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Table 2: Data representing the total body weight gain pre-leptin and total body weight loss post
leptin treatment (n=5).
Average Weight Gain Pre-leptin And Total weight loss Post Leptin Treatment (g)
Pre leptin (Weight gain)

Post Leptin (Weight loss)

32

15.3

27.7

7.9

7.4

6.4

28.5

8

24.3

13.9

Mean

Mean

24

13.7

SEM

SEM

4.33

3.64

Figure 8: Average weight gain of pre- and post-leptin treatment. There was a significant
(p<0.05) weight loss post-leptin treatment (n=5) using a Paired t-test analysis. (
difference)
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* significant

Leptin Effect on Body Weight
Leptin treatment of rats with irregular oestrus cycle resulted in lower weight gain compared
to RCD+S and HFD+S as shown in the table (table 3) and figure (figure 9) below.

Table 3: This data represents the differences in the total weight gained of the RCD+S (n=6),
HFD+Leptin (n=5), and HFD+S (n=9) at the end of 15 weeks

Average Weight Gain Of RCD+S, HFD+Leptin, and HFD+S At The End Of 15 Weeks (g)
RCD+S

HFD+Leptin

HFD+S

24.5

16.8

43.1

28.8

19.8

35.5

18.6

1.0

42.1

8.3

20.5

25.1

17

10.4

33.1

30

33.4
44.6
28.5
30.3

Mean

Mean

Mean

21.2

13.7

35.08

SEM

SEM

SEM

3.35

3.64

2.29
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Average Weight Gain of RCD+S, HFD+Leptin, and HFD+S at the End of 15 Weeks

Figure 9: Average weight gain Of RCD+S, HFD+leptin, and HFD+S at the end of 15 weeks.
Using a One-way ANOVA analysis test, HFD+S (n=9) was significantly (p<0.05) higher than
RCD+S (n=6) and HFD+Leptin (n=5) rats. (

* significant difference)

Leptin Reduces Amount of Food Intake
During this study, the amount of food intake by each rat was monitored everyday
throughout the study with the use of a digital scale (Mettler Toledo,OH). This parameter was
measured to determine if leptin reduces appetite. Leptin caused reduction of the amount of
food intake by these rats, which directly had an effect on their body weight change. The
HFD+leptin group of rats resulted in a significant reduction in food intake measured in kcal/day
when compared to RCD+S and HFD+S as shown in the table (table 4) and figure (figure 10)
below. A gram of RCD diet correlates to 3.4 kcal, while a gram of HFD correlates to 4.73 kcal.
After the treatment with leptin, there was reduction of food intake of HFD+leptin due to loss of
appetite induced by effect of leptin.
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Table 4: Average food Intake (kcal/day) of RCD+S, HFD+S, and HFD+Leptin.

Average Food Intake (kcal/day)
RCD+S

HFD+S

HFD+Leptin

45.76

52.79

43.04

SEM

SEM

SEM

0.02

0.05

0.03

Figure 10: This figure shows the average food intake (kcal/day) of RCD+S, HFD+S, and
HFD+Leptin. The calorie intake of the HFD+S was significantly (p<0.05) higher than the
RCD+S and HFD+leptin, using a One-way ANOVA analysis test. (
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* significant difference)

Leptin Modulates E-Cadherin and β-Catenin
Ovary cell lysate were analyzed for the expression of β-catenin and E-cadherin by Western
Blot. It was found that both of these proteins had higher expression levels in rats given RCD+S
when compared to HFD+S and HFD+L. There was a significant reduction of β-catenin and Ecadherin in the HFD+S when compared to RCD+S as shown in the figure (figure 11) below.
However, the rats fed HFD followed by leptin injection resulted in an increased expression of βcatenin and E-cadherin compared to HFD+S, suggesting leptin induced a recovery from the
almost total loss of expression of both β-catenin and E-cadherin due to the effect of obesity on
infertility.

Figure 11: Effects of leptin on expression of (a) β-catenin and (b) E-cadherin in obese
infertile ovary cells. Reversal of expression of both proteins in HFD+leptin towards the
amount expressed in RCD+S, after almost total loss in HFD+S. (c) Expression of β-actin
in the cells, serving as a form of loading control. β-actin, a 44kDa primary antibody, is a
house keeping gene that is always in the cell and serves as a form of loading control. This
shows that the same amount and concentration of protein was loaded in each well.
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CHAPTER 4
DISCUSSION

Leptin is a pleiotropic hormone that has been found to be involved in many physiological
functions in the body (9-11). Although leptin has been found to reverse infertility (14), its role in
infertility reversal in obese individuals has not yet been examined. The focus of this study is to
propose the probable mechanism of leptin in the reversal of infertility in dietary-induced obese
infertile rats.

Our first observation was the role of leptin in energy intake and expenditure, which supports
previous studies that show leptin regulates appetite, weight gain, and fat deposition via a
negative feedback loop involving the hypothalamus (1-4). It was observed that the rats given
HFD+leptin had a reduction in their food intake that led to a significant weight loss when
compared to rats given HFD+S.

Also, the role of leptin in fertility was observed. HFD feeding for 15 weeks induced irregular
oestrus cycle an indicator of infertility in all the rats. The regularity of oestrus cycle was
determined by a 4-day cycle that consists of: proestrus, estrus, metestrus, and diestrus. The
ability of each rat to go through this cycle day by day without skipping any stage signified a
regular oestrus cycle. Two weeks post-leptin injection in the treated group, the irregular oestrus
cycle became regular. Leptin is known to reverse infertility in ob/ob infertile rats (14).
Exogenous leptin replacement has been found to rescue the infertility of ob/ob females (20).
Elevated serum luteinizing hormone, increase in ovarian and uterine weights, and stimulation of
ovarian and uterine histology has been documented with exogenous leptin replacement (20).
Some studies have supported the concept of leptin coordinating the behavioral and endocrine
components of reproductive functions (44-45).
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Although recent studies have shown that leptin reverses infertility in ob/ob infertile rats (20),
the pathway of reversal is poorly understood. This study will be the first to show the correlation
between leptin and a potential pathway in the reversal of fertility in dietaryly induced obese
infertile rats. The possibility of calorie restriction/and or weight loss pathway has been excluded
(14, 16).

Most importantly, studies have shown that E-cadherin/β-catenin complex is among the
structural molecular constituents that assemble to form the adherens-junctions (53). These
adherens junction are needed for the creation and maintenance of epithelial cell layers, which is
achieved by regulating cell growth and adhesion between cells (53). This complex has also
been found to play a crucial role in maintaining epithelial integrity and cell proliferation (35).
Expressions of E-cadherin and β-catenin were found to be increased in the theca and interstitial
cells of the rat ovaries during follicular development (58, 64, 65). However, granulosa cells had
more expression of β-catenin (58, 64, 65). The concentration of E-cadherin and β-catenin were
found to be constant during the follicular phase and present in most ovarian cells at all stages of
folliculogenesis (58, 64, 65). Folliculogenesis is the process of attaining successively higher
levels of cell organization by means of cytodifferentiation and cell proliferation of the ovarian
follicle (60). The conversion of primordial follicles to primary follicles involves the development
of intimate intercellular connections between the oocyte and granulosa cells (63, 29). The
effectiveness of this cell-cell contact is determined by the competency of adherens junction and
gap junction at this region (59). The intimate intercellular connections between the oocyte and
granulose cells are important in primary follicle development (59). Also, primary-to-secondary
transition involves the ability to stimulate granulosa cell proliferation and continual development
of inter-cellular junction system between the granulosa cells and oocyte-granulosa intercellular
connections (59). The importance of oocyte-granulosa intercellular connections in primordial
follicles-primary follicles transition and the stimulation of granulosa cell proliferation and
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continual development of intercelluar junctional system between the granulose cell and oocytegranulosa connections (59), make the E-cadherin/β-catenin complex a potential candidate for a
crucial role in folliculogenesis.
In our studies, not did we only demonstrate that E-cadherin and β-catenin are expressed in
the rat ovary and that HFD reduced their expression, but surprisingly we also showed that leptin
treatment modulates the expression of these proteins in these dietary-induced obese infertile
rats. The expression of E-cadherin and β-catenin was markedly reduced in ovaries of rats that
were fed with high fat diet (HFD) and reversed expression of these proteins when they were
treated with leptin intra-peritoneally. Because E-cadherin/β-catenin complex has been found to
be involved in all stages of folliculogenesis (38,41), observations made in this study suggest that
leptin has a functional role in the expression of E-cadherin and β-catenin complex in improving
fertility in obese infertile rats and could therefore be important in folliculogenesis and ovulation.
This could be a novel finding of the potential pathway by which leptin acts in reversing infertility
in these rats.
Future Directions
A long-term study including measurement of all the hormones involved in reproduction is
needed. The ovarian and uterine weights should also be measured. In respect to the counter
effects of E-cadherin and β-catenin that have been recently found to be involved in development
of cancer and its metastasis (25,34), it will be of interest to know if these leptin treated rats will
develop ovarian cancer or polycystic ovarian disease when they are left for a longer period of
time.
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